AL

Arthur C. Ley

DY Dyax: 24 patents #2 of 129Top 2%
PE Protein Engineering: 5 patents #1 of 6Top 20%
TL Takeda Pharmaceutical Company Limited: 1 patents #859 of 1,531Top 60%
Overall (All Time): #124,080 of 4,157,543Top 3%
30
Patents All Time

Issued Patents All Time

Showing 25 most recent of 30 patents

Patent #TitleCo-InventorsDate
11344610 Prevention and reduction of blood loss Robert Charles Ladner, Shirish Hirani, Anthony Williams 2022-05-31
10245307 Prevention and reduction of blood loss Robert Charles Ladner, Shirish Hirani, Anthony Williams 2019-04-02
9480733 Prevention and reduction of blood loss Robert Charles Ladner, Shirish Hirani, Anthony Williams 2016-11-01
9114144 Kallikrein-inhibitor therapies Robert Charles Ladner, Shirish Hirani, Anthony Williams, Maria Grazia De Simoni, Luigi Bergamaschini 2015-08-25
8710007 Prevention and reduction of blood loss Robert Charles Ladner, Shirish Hirani, Anthony Williams 2014-04-29
8124586 Prevention and reduction of blood loss Robert Charles Ladner, Shirish Hirani, Anthony Williams 2012-02-28
8034775 Kallikrein-inhibitor therapies Robert Charles Ladner, Shirish Hirani, Anthony Williams 2011-10-11
7893007 Directed evolution of novel binding proteins Robert Charles Ladner, Sonia Guterman, Bruce Lindsay Roberts, William Markland, Rachel Kent 2011-02-22
7851442 Prevention and reduction of blood loss Robert Charles Ladner 2010-12-14
7811991 Prevention and reduction of blood loss Robert Charles Ladner 2010-10-12
7704949 Kallikrein-inhibitor therapies Robert Charles Ladner, Shirish Hirani, Anthony Williams, Maria Grazia Simoni, Luigi Bergamaschini 2010-04-27
7550427 Poly-pegylated protease inhibitors Aaron Sato, Robert Charles Ladner, Mark Stochl 2009-06-23
7413537 Directed evolution of disulfide-bonded micro-proteins Robert Charles Ladner, Sonia Guterman, Bruce Lindsay Roberts, William Markland, Rachel Kent 2008-08-19
7276480 Prevention and reduction of blood loss Robert Charles Ladner, Shirish Hirani, Anthony Williams 2007-10-02
7211395 Serum albumin binding moieties Aaron Sato, Edward H. Cohen 2007-05-01
7208293 Directed evolution of novel binding proteins Robert Charles Ladner, Sonia Guterman, Bruce Lindsay Roberts, William Markland, Rachel Kent 2007-04-24
7153829 Kallikrein-inhibitor therapies Robert Charles Ladner, Shirish Hirani, Anthony Williams, Maria Grazia De Simoni, Luigi Bergamaschini 2006-12-26
7118879 Method of recovering a nucleic acid encoding a proteinaceous binding domain which binds a target material Robert Charles Ladner, Sonia Guterman, Bruce Lindsay Roberts, William Markland, Rachel Kent 2006-10-10
7078383 ITI-D1 Kunitz domain mutants as HNE inhibitors Sonia Guterman, William Markland, Rachel Kent, Bruce Lindsay Roberts, Robert Charles Ladner 2006-07-18
7064107 Prevention and reduction of blood loss Robert Charles Ladner, Shirish Hirani, Anthony Williams 2006-06-20
6989369 Kunitz domain peptides Robert Charles Ladner 2006-01-24
6979538 Directed evolution of novel binding proteins Robert Charles Ladner, Sonia Guterman, Bruce Lindsay Roberts, William Markland, Rachel Kent 2005-12-27
6906176 Enterokinase cleavage sequences Christopher Luneau, Robert Charles Ladner 2005-06-14
5837500 Directed evolution of novel binding proteins Robert Charles Ladner, Sonia Kosow Gutterman, Bruce Lindsay Roberts, William Markland, Rachel Kent 1998-11-17
5663143 Engineered human-derived kunitz domains that inhibit human neutrophil elastase Robert Charles Ladner, Sonia Guterman, Bruce Lindsay Roberts, William Markland, Rachel Kent 1997-09-02